Key Applications of Semaglutide Initially developed for the management of type 2 diabetes, Semaglutide has expanded its utility due to its significant weight loss benefits
Many insurance companies require a Prior Authorization (PA)
The blood pressure targets should be individualised and account for possible adverse outcomes, such as postural hypotension, which is particularly relevant in people with concurrent autonomic neuropathy
5,9 Conclusion Weight loss injections, specifically GLP-1 receptor agonists like semaglutide and liraglutide, offer a promising avenue for individuals who have struggled with obesity and its associated health complications
Weight reduction is a known effect of GLP-1 receptor agonist therapies, and some, such as liraglutide, are licensed to treat individuals with obesity in some countries [37, 38]
Strong consumer demand and lack of competition has kept prices high, with out-of-pocket costs reaching over $1,000 per month before insurance, rebates and discounts